Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 38101 - 38125 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	PDPN	10630	upregulated	entinostat results in increased expression of PDPN mRNA	1p36.21	A21037
Entinostat	Investigational	PDYN	5173	upregulated	entinostat results in increased expression of PDYN mRNA	20p13	A21037 A21035
Entinostat	Investigational	PELO	53918	upregulated	entinostat results in increased expression of PELO mRNA	5q11.2	A21035
Entinostat	Investigational	PER1	5187	upregulated	entinostat results in increased expression of PER1 mRNA	17p13.1	A21037
Entinostat	Investigational	PER2	8864	downregulated	entinostat results in decreased expression of PER2 mRNA	2q37.3	A21035
Entinostat	Investigational	PEX13	5194	downregulated	entinostat results in decreased expression of PEX13 mRNA	2p15	A21037
Entinostat	Investigational	PEX5L	51555	downregulated	entinostat results in decreased expression of PEX5L mRNA	3q26.33	A21035
Entinostat	Investigational	PF4	5196	downregulated	entinostat results in decreased expression of PF4 mRNA	4q13.3	A21035
Entinostat	Investigational	PFKFB3	5209	downregulated	entinostat results in decreased expression of PFKFB3 mRNA	10p15.1	A21035
Entinostat	Investigational	PFKP	5214	upregulated	entinostat results in increased expression of PFKP mRNA	10p15.2	A21037 A21035
Entinostat	Investigational	PGAP1	80055	downregulated	entinostat results in decreased expression of PGAP1 mRNA	2q33.1	A21037
Entinostat	Investigational	PGF	5228	upregulated	entinostat results in increased expression of PGF mRNA	14q24.3	A21037
Entinostat	Investigational	PGM1	5236	upregulated	entinostat results in increased expression of PGM1 mRNA	1p31.3	A21037
Entinostat	Investigational	PHC1	1911	upregulated	entinostat results in increased expression of PHC1 mRNA	12p13.31	A21037
Entinostat	Investigational	PHC2	1912	downregulated	entinostat results in decreased expression of PHC2 mRNA	1p35.1	A21037
Entinostat	Investigational	PHF20L1	51105	downregulated	entinostat results in decreased expression of PHF20L1 mRNA	8q24.22	A21037 A21035
Entinostat	Investigational	PHLDA1	22822	upregulated	entinostat results in increased expression of PHLDA1 mRNA	12q15	A21037
Entinostat	Investigational	PHLDA2	7262	upregulated	entinostat results in increased expression of PHLDA2 mRNA	11p15.4	A21037
Entinostat	Investigational	PHLDB3	653583	upregulated	entinostat results in increased expression of PHLDB3 mRNA	19q13.31	A21035
Entinostat	Investigational	PHOX2B	8929	downregulated	entinostat results in decreased expression of PHOX2B mRNA	4p13	A21035
Entinostat	Investigational	PHTF2	57157	downregulated	entinostat results in decreased expression of PHTF2 mRNA	7q11.23-q21.11	A21037
Entinostat	Investigational	PID1	55022	upregulated	entinostat results in increased expression of PID1 mRNA	2q36.3	A21037
Entinostat	Investigational	PIFO	128344	upregulated	entinostat results in increased expression of PIFO mRNA	1p13.2	A21037
Entinostat	Investigational	PIGH	5283	upregulated	entinostat results in increased expression of PIGH mRNA	14q24.1	A21035
Entinostat	Investigational	PIK3AP1	118788	upregulated	entinostat results in increased expression of PIK3AP1 mRNA	10q24.1	A21035

Displaying entries 38101 - 38125 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability